Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

A systematic review and meta-analysis explored the relationship between androgen deprivation therapy and risk for heart failure in men with prostate cancer who were treated with ADT.

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

"These findings reinforce the use of dapagliflozin, 10 mg, or other SGLT2 inhibitors when the therapeutic goal is to reduce ...

A higher risk of HF hospitalization was seen with dapagliflozin over empagliflozin, but one researcher urges caution.

The company shared interim results from an ongoing Phase II trial examining its recombinant antibody fusion protein.

However, the benefits of beta-blockers in “stiff heart” heart failure are less clear. This condition, also known as heart ...

Neglecting high blood pressure can increase the risk of a very serious disease. High blood pressure doesn’t just affect your ...

Popular medications approved for weight loss, diabetes, and heart disease may have health benefits beyond weight loss, and blood sugar control, but there are risks too.

Researchers took drugs currently used to treat type 2 diabetes and obesity and looked into how they affect 175 conditions.

People with hidden pockets of fat in their muscles – similar to so-called marbling in beef – are at a higher risk of dying from heart attacks or heart failure regardless of their body weight, ...

About half of U.S. adults have high blood pressure, a major risk for heart attacks, strokes, kidney failure, even dementia.